Biofrontera Inc.

0.06
0.00 (3.45%)
At close: Mar 03, 2025, 3:59 PM

Biofrontera Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue 34.07M 28.67M 24.1M 18.85M 26.18M
Cost of Revenue 17.44M 15.19M 12.74M 9.07M 12.41M
Gross Profit 16.63M 13.49M 11.36M 9.78M 13.77M
Operating Income -22.68M -22.38M -25.85M -8.33M -14.92M
Interest Income 132K 175K 16K 28K 25K
Pretax Income -20.12M -608K -37.66M -10.92M -10.95M
Net Income -20.13M -640K -37.71M -10.99M -10.98M
Selling & General & Admin 39.13M 35.87M 37.21M 18.12M 28.7M
Research & Development 77K n/a n/a n/a n/a
Other Expenses 100K 33K 689K 1.25M 5.48M
Operating Expenses 39.3M 35.87M 37.21M 18.12M 28.7M
Interest Expense 600K 195K 344K 2.9M 2.16M
Selling & Marketing Expenses 1.43M 100K 500K n/a n/a
Cost & Expenses 56.75M 51.05M 49.95M 27.18M 41.1M
Income Tax 14K 32K 56K 64K 33K
Shares Outstanding (Basic) 1.55M 1.06M 855.24K 580K 607K
Shares Outstanding (Diluted) 1.55M 1.06M 855.24K 580K 607K
EPS (Basic) -13.02 -0.61 -44.1 -18.94 -18.09
EPS (Diluted) -13.02 -0.61 -44.1 -18.94 -18.09
EBITDA -18.45M 934K -36.76M -7.49M -8.15M
Depreciation & Amortization 1.06M 1.17M 540K 562K 667K